Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Inflammation × Specimen Handling × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Prostatic Neoplasms 25 Lung Neoplasms 23 Carcinoma, Non-Small-Cell Lung 23 Leukemia, Myeloid, Acute 17 Breast Neoplasms 16 Multiple Myeloma 15 Urinary Bladder Neoplasms 13 Carcinoma, Renal Cell 13 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma 11 Neoplasm Metastasis 10 Myelodysplastic Syndromes 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Pancreatic Neoplasms 9 Glioma 9 Squamous Cell Carcinoma of Head and Neck 8 Myeloproliferative Disorders 8 Mouth Neoplasms 8 Glioblastoma 8 Colorectal Neoplasms 8 Ovarian Neoplasms 7 Melanoma 7 Leukemia, Myelomonocytic, Chronic 7 Wilms Tumor 6 Triple Negative Breast Neoplasms 6 Sarcoma 6 Oropharyngeal Neoplasms 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Laryngeal Neoplasms 6

Interventions

XENP 1595 2 salicylsalicylic acid 1 microcrystalline cellulose 1 ginger extract 1 epigallocatechin gallate 1 dapagliflozin 1 Tablets 1 Sulindac 1 Specimen Handling 1 Sodium Salicylate 1 Radiotherapy, Conformal 1 Pregabalin 1 Omeprazole 1 Losartan 1 Ketorolac 1 Interleukin 1 Receptor Antagonist Protein 1 Infliximab 1 Etanercept 1 Atorvastatin 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡